Search research articles
Contact Us
Filters
Showing results (1-10 of 69) with videos related to
Page
of 7
Sort By:
The Prostate
|
June 3, 2022
PTEN-PI3K pathway alterations in advanced prostate cancer and clinical implications
Atish D Choudhury
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2019
Retinoblastoma Loss in Cancer: Casting a Wider Net
Atish D Choudhury, Himisha Beltran
Lancet (London, England)
|
February 14, 2021
Transdermal oestrogen for advanced prostate cancer
Charlene Mantia, Atish D Choudhury
European Urology Oncology
|
December 3, 2021
Towards Biologically Driven Decision-making in Metastatic Hormone-sensitive Prostate Cancer
Himisha Beltran, Atish D Choudhury
European Urology Focus
|
January 15, 2023
Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate Cancer
Praful Ravi, Atish D Choudhury
Current Opinion in Urology
|
October 15, 2019
Biological and therapeutic advances in the pursuit of effective immunotherapy for prostate cancer
Anis A Hamid, Atish D Choudhury
Cancer Treatment and Research
|
November 17, 2023
Development of PARP Inhibitors in Targeting Castration-Resistant Prostate Cancer
Kent W Mouw, Atish D Choudhury
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
Mutual ATRaction: Assessing Synergy of Berzosertib with Sacituzumab Govitecan
Stephanie A Berg, Atish D Choudhury
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
New agents in metastatic prostate cancer
Atish D Choudhury, Philip W Kantoff
The Journal of Biological Chemistry
|
May 29, 2004
Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression
Atish D Choudhury, Hong Xu, Richard Baer
Page
of 7
Search research articles
Search
Showing results (1-10 of 69) with videos related to
Sort By:
Page
of 7
The Prostate
|
June 3, 2022
PTEN-PI3K pathway alterations in advanced prostate cancer and clinical implications
Atish D Choudhury
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 19, 2019
Retinoblastoma Loss in Cancer: Casting a Wider Net
Atish D Choudhury, Himisha Beltran
Lancet (London, England)
|
February 14, 2021
Transdermal oestrogen for advanced prostate cancer
Charlene Mantia, Atish D Choudhury
European Urology Oncology
|
December 3, 2021
Towards Biologically Driven Decision-making in Metastatic Hormone-sensitive Prostate Cancer
Himisha Beltran, Atish D Choudhury
European Urology Focus
|
January 15, 2023
Defining Patient Benefits from High-intensity Intermittent Therapy for Hormone-sensitive Prostate Cancer
Praful Ravi, Atish D Choudhury
Current Opinion in Urology
|
October 15, 2019
Biological and therapeutic advances in the pursuit of effective immunotherapy for prostate cancer
Anis A Hamid, Atish D Choudhury
Cancer Treatment and Research
|
November 17, 2023
Development of PARP Inhibitors in Targeting Castration-Resistant Prostate Cancer
Kent W Mouw, Atish D Choudhury
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2023
Mutual ATRaction: Assessing Synergy of Berzosertib with Sacituzumab Govitecan
Stephanie A Berg, Atish D Choudhury
Journal of the National Comprehensive Cancer Network : JNCCN
|
November 10, 2012
New agents in metastatic prostate cancer
Atish D Choudhury, Philip W Kantoff
The Journal of Biological Chemistry
|
May 29, 2004
Ubiquitination and proteasomal degradation of the BRCA1 tumor suppressor is regulated during cell cycle progression
Atish D Choudhury, Hong Xu, Richard Baer
Page
of 7